PLUS1
0.66
-0.02 (-2.94%)
-0.02 (-2.94%)
Upgrade to Real-Time
Market Closed
Low
0.64
High
7.52
Best deals to access real time data! |
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
|
|
TSX Level 1
Monthly Subscription
for only
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Antibe Therapeutics Inc | ATE | Toronto | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
 |
|
|---|---|---|---|---|
| -0.02 | -2.94% | 0.66 | 15:03:34 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.67 | 0.65 | 0.70 | 0.66 | 0.68 |
| Trades | Stocks Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 60 | 48,053 | - | 0.64 - 7.52 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:59:30 | 500 | $ 0.66 | CAD |
Period:
Draw Mode:
Antibe Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 34.07M | 5.63M | 5.63M | $ 9.84M | $ 0.00 | -0.66 | -1.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 40.41k | $ - | - | 0.00 | - |
Antibe Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.77 | 0.77 | 0.65 | 0.6978952 | 76,121 | -0.11 | -14.29% |
| 1 Month | 0.67 | 0.78 | 0.64 | 0.6909807 | 82,804 | -0.01 | -1.49% |
| 3 Months | 0.94 | 1.01 | 0.64 | 0.7603014 | 97,437 | -0.28 | -29.79% |
| 6 Months | 3.58 | 3.64 | 0.64 | 1.09 | 242,642 | -2.92 | -81.56% |
| 1 Year | 3.98 | 7.52 | 0.64 | 2.64 | 203,980 | -3.32 | -83.42% |
| 3 Years | 0.415 | 7.52 | 0.375 | 2.34 | 220,298 | 0.245 | 59.04% |
| 5 Years | 0.415 | 7.52 | 0.375 | 2.34 | 220,298 | 0.245 | 59.04% |
Antibe Therapeutics Description
| Antibe Therapeutics Inc develops and out-licenses new pharmaceuticals. |
